Navigation Links
AMN Healthcare Reports Fourth Quarter and Year End 2007 Results; Provides Full Year 2008 Guidance
Date:2/26/2008

SAN DIEGO, Feb. 26 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS), the nation's largest healthcare staffing company, today reported revenue for the fourth quarter of 2007 of $285.9 million. This represents an increase of 0.8% from the $283.5 million reported for the same quarter last year, and a 4.8% decline from the $300.3 million in revenue reported in the third quarter. The sequential decline in revenue was due in part to the typical fourth quarter seasonality of fewer clinicians working over the holidays. Diluted earnings per share for the fourth quarter of 2007 were $0.26, a decrease of $0.03 compared to last year and last quarter. Fourth quarter 2006 diluted earnings per share included a benefit equating to $0.05 due to favorable actuarial adjustments to the professional liability insurance reserve.

Revenue for the full year 2007 was an industry record $1.16 billion, an increase of 7.6% from the $1.08 billion reported for 2006. While the company was able to produce operating efficiencies throughout the year, these were partially offset by direct cost pressures and lower demand levels in the nurse staffing business that caused diluted earnings per share to grow at a slower rate of 2.9% to $1.05.

"During the fourth quarter we continued to see the benefit of the diversified service strategy we have been implementing over the past three years. While economic and market conditions have impacted our nurse staffing business recently, our locum tenens staffing segment continued to experience strong year-over-year growth. We also saw the sustained benefit of initiatives implemented earlier in the year to improve gross margins and drive efficiencies across all business segments," said Susan R. Nowakowski, Pre
'/>"/>

SOURCE AMN Healthcare Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Advanced Life Sciences to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference
2. Agfa HealthCare, InterComponentWare, and Sun Microsystems Join Open eHealth Foundation at HIMSS08
3. Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008
4. Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure
5. BancTec Takes Leadership Position in Helping to Create Better Value, Lower Transaction Costs in Healthcare Industry
6. Thomson Healthcare Announces Enhancements to Order Sets Solution
7. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
8. Seal Shield Introduces New Silver Seal Washable, Antimicrobial Mouse at HiMSS Healthcare Symposium
9. Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows
10. Billians HealthDATA(R) Continues to Delight Their Customers with Comprehensive Cutting Edge Healthcare Market Intelligence
11. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... , PRINCETON, N.J., Nov. 27 Th...most double over the next 25 years and annual medi...36 billion, up from $113 billion today, according ...betes Care . The National Changing Diabetes ...issioned the analysis by a team from the Universit...
(Date:11/26/2009)... that,s too big or too heavy can lead to strains o... News) -- There may be nothing wrong with stuffing...ant to do the same thing with your suitcase as you...ple were treated in 2008 in U.S. hospital emergenc...al facilities for luggage-related injuries, such a...
(Date:11/26/2009)... Dr. David Kim of the Live Life ...gery in Dallas , is one of a growing number of phy...l networking sites to connect with individuals who...to fight morbid obesity. Dr. Kim is utilizing Face...ion about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offe...r users of Yaz and Yasmin birth control pills who ...ary Embolism, Stroke, Heart Attack or other relate... Women can call toll free at 1-800-856-6405 or go ...w.com and fill out an online case evaluation form...
(Date:11/25/2009)... , EMERYVILLE, Calif., Nov. 25 /PRNewswire-Fir...ONXX ) today announced that the company will host ...ing ,, December 7, 2009 - 9:00 a.m. CT/10:...scuss data presentations surrounding carfilzomib i...featured at the 51st American Society of Hematolog...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...Testicular cancer usually strikes men between 20 a...otherapy have // led to an improved survival rate ... are so young, concern about the effect of the can...nged. These conflicting results suggested the need...
...Colon cancer is the third most common form of canc...dy researchers say // estrogen may provide protect... may help minimize the number and size of tumors t... effects of specific ingredients. Diet one contain...
...Women who took the most antibiotics , or who took ...e risk of // developing breast cancer over an aver...n't use the drugs, the study showed. Also, sinc... be that women who never took the drugs were unusu...
...The lifetime risk for depression in women ranges f...ence occurring during // the childbearing years. S...ant women suffer from depression and up to 35 perc...believe these drugs can be safely prescribed for p...
...PSA tests for men and breast self-examination by w...ous value.// However neither of these tests ha...ates. PSA levels in the blood can predict mortalit...The reason: many prostate cancers never develop to...
...The human disease believed to be caused by eating ...// caused by blood transfusions from infected indi...dy. In two studies, investigators outline the p...encephalopathy (BSE), can be transmitted through a...
Other Medicine News:
(Date:11/25/2009)...The Netherlands and JOHANNESBURG, November 25 /PRN...ion and Pyxis Discovery announced today,that they ...arket both,companies, services. , Pyxis,s...overy expertise,will be coupled with iThemba,s ser...hemistry support to projects identified through Py...
(Date:11/25/2009)...Calif., Nov. 25 ChemoCentryx, In...a from the Company,s PROTECT-1 (the Prospective Ra...e Trial) of Traficet-EN(TM) (CCX282-B) in patients...ted clinical efficacy with a favorable safety and ...ence of clinical efficacy in the reduction of dise...
(Date:11/24/2009)...ov. 24 ,, WHAT: Rom Houbens, ...years following an auto accident, was actually ful...e subject of a Good Morning America segment. The ...strate how people with Locked-in Syndrome and othe... Good Morning America -- Tuesday, November 24 a...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 1Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 3Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 1Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 2NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 1NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 2
...tigator Meeting for European Participants in Phase...d Population, BERKELEY HEIGHTS, N.J., Sept. 5 /PR... GNTA ) announced that data from the Company,s Pha...s chemotherapy would be,presented at the opening s...ing organized by the European Association of Derma...
... Data Scheduled for Presentation at 47th ICAAC on ...ARLSBAD, Calif., Sept. 4 Ardea Biosciences,Inc. (...cessfully completed,Phase 1 single-ascending-dose,...teraction studies of RDEA806, a novel HIV non-nucl... healthy volunteers. The data from these Phase 1 ...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: